Angiopoietin balance in septic shock patients treated by direct hemoperfusion with polymyxin B-immobilized fiber

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 6, 2009, Pages 520-527

  Ebihara, Itaru ^a   Hirayama, Kouichi ^b   Nagai, Kei ^a   Kakita, Tomoko ^b   Miyamoto, Yasunori ^b   Nagai, Miho ^b   Ogawa, Yujiro ^b   Fujita, Shogo ^b   Shimohata, Homare ^b   Kai, Hirayasu ^c   Usui, Joichi ^c   Yamagata, Kunihiro ^c   Kobayashi, Masaki ^b  

^a MITO SAISEIKAI GENERAL HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angiopoietin 1; Angiopoietin 2; Direct hemoperfusion with polymyxin B immobilized fiber column; Sepsis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; NAFAMSTAT MESILATE; POLYMYXIN B;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIAFILTRATION; HEMOPERFUSION; HUMAN; MALE; MATERIAL COATING; POLYMYXIN B IMMOBILIZED FIBER COLUMN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEPTIC SHOCK; SURVIVAL RATE; SURVIVOR; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVORS;

EID: 71949109858     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00777.x     Document Type: Article

References (26)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003 348 : 1546 1554.
2. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-sepsis study group. Am J Respir Crit Care Med 1996 154 : 617 24.
3. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989 84 : 1470 1478.
4. Millauer B, Wizigmann-Voos S, Schnürich M et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993 72 : 835 846.
5. Koh GY, Kim I, Kwak HJ, Yun MJ, Leem JC. Biomedical significance of endothelial cell specific growth factor, angiopoietin. Exp Mol Med 2002 34 : 1 11.
6. Davis S, Aldrich TH, Jones PF et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996 87 : 1161 1169. (Pubitemid 27010100)
7. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2 ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998 273 : 18514 21.
8. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 277 : 55 60.
9. Asahara T, Chen D, Takahashi T et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998 83 : 33 40.
10. Stratmann A, Risau W, Plate KH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998 153 : 1459 1466.
11. Hayes AJ, Huang WQ, Yu J et al. Expression and function of angiopoietin-1 in breast cancer. Br J Cancer 2000 83 : 1154 1160.
12. Tani T, Hanasawa K, Endo Y et al. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998 22 : 1038 1044.
13. Ebihara I, Hirayama K, Kaneko S et al. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with polymyxin B-immobilized fiber. Ther Apher Dial 2008 12 : 285 291.
14. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 101 : 1644 1655.
15. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981 9 : 591 597.
16. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999 237 : 97 132. (Pubitemid 28554861)
17. Thurston G, Suri C, Smith K et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999 286 : 25112514.
18. Gamble JR, Drew J, Trezise L et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000 87 : 603 607.
19. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005 111 : 97 105.
20. Mofarrahi M, Nouh T, Qureshi S, Guillot L, Mayaki D, Hussain SN. Regulation of angiopoietin expression by bacterial lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2008 294 : L955 63.
21. Parikh SM, Mammoto T, Schultz A et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006 3 : e46.
22. Orfanos SE, Kotanidou A, Glynos C et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007 35 : 199 206.
23. Kawamata T, Imaizumi H, Yoshida M, Kaneko M. polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 1997 23 : 130 131.
24. Jaber BL, Barrett TW, Neto MC, Sundaram S, King AJ, Pereira BJG. Removal of cytokine inducing substances by polymyxin-B immobilized polystyrene- derivative fibers during in vitro hemoperfusion of 10% human plasma containing Staphylococcus aureus challenge. ASAIO J 1998 44 : 48 53.
25. Pober JS, Cotran RS. Cytokine and endothelial activation. Physiol Rev 1990 70 : 427 451.
26. Kushi H, Nakahara J, Miki T, Okamoto K, Saito T, Tanjo K. Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial 2005 9 : 303 307.